About Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
During the past decade, Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
According to Clinical.Site data, the most researched conditions in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum" are
"Breast Cancer" (2 trials). Many other conditions were trialed in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum" in a lesser frequency.
Clinical Trials Intervention Types at Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
Most popular intervention types in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials) and "Epirubicin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
The vast majority of trials in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum" are
2 trials for "All" genders.
Clinical Trials Status at Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum
Currently, there are NaN active trials in "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".